A study on serological detection of Hepatitis A virus with associated risk factors in young kids

Aysha Iqbal Khan, Rana Haider Ali, Hafiz Muhammad Usman Siddiq, Suleman Irfan, Hafiz Muhammad Usman Siddiq, Noor Fatima, Ramla Zafar

Abstract


Background: Hepatitis A virus (HAV) is a major concerning issue for human health that causes acute viral hepatitis. Hepatitis A virus is non enveloped RNA virus which is a member of the family Picornaviridae and genus Hepatovirus. HAV is more prevalent in developing countries like Pakistan with poor sanitation and economic status. The virus is present in young kids of age 1 to 15 years old associated with many risk factors.

Methods: A total of 100 blood samples (1-2 ml) were collected from the hospitals of Lahore. After serum collection, indirect ELISA was performed on a commercially available kit. The Optical density (OD) was taken from the ELISA reader. Positive and negative samples were also run along with the samples and samples OD was compared with the OD of positive and negative controls. Cut off value was calculated by multiplying negative control (NC) with 2.1. The absorbance value of specimen/cutoff <1: samples having a value less than cut-off value were considered negative and samples having a value greater than or equal to cut-off value were considered positive. The apparent prevalence of Hepatitis A virus was measured by dividing the number of children positive to the total number of children included in the study.

Results: Of the 100 samples tested, 37% were positive for IgM and 100% were positive for IgG. Statistical Analysis SPSS 21.0 version was applied to analyze the data and a correlation test was applied to see the association of risk factors with disease status.

Conclusion: This study was done to appraise the overall status of HAV prevalence in young kids in association with potential risk factors.

Keywords: Hepatitis A; ELISA; Risk assessment; Prevalence; Hygiene 


Full Text:

PDF

References


Syed R, Mohammed AH, Sindiri PK, Nathani AA, Rao RV, Satti VP, Chandra M, Khaja MN. Seroepidemiology of hepatitis A virus in Hyderabad, South India. Journal of Medical & Allied Sciences, (2012); 2(2): 58.

Bonanni P, Boccalini S, Bechini A. Vaccination against hepatitis A in children: A review of the evidence. Therapeutics and Clinical Risk Management, (2007); Dec;3(6):1071.

Ciaccia MC, Moreira RC, Ferraro AA, Lemos MF, Oba IT, Porta G. Epidemiological and serological aspects of hepatitis A among children and teenagers in the city of Santos: a cross-sectional study. São Paulo Medical Journal, (2012);130(4):230-5.

Ayouni, K., Naffeti, B., Ben Aribi, W. et al. Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact. BMC Infectious Disease (2020); 20, 627.

Lemon, Stanley M., and David L. Thomas. "Vaccines to prevent viral hepatitis." New England journal of medicine 336.3 (1997): 196-204.

European Food Safety Authority (EFSA). Update: Outbreak of Hepatitis A virus infection in Italy and Ireland (2013); (Vol. 10, No. 7, p. 459E).

Bohm K, Filomena A, Schneiderhan-Marra N, Krause G, Sievers C. Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine, (2017); Oct 13;35(43):5883-9.

Hofmeister, Megan G., Monique A. Foster, and Eyasu H. Teshale. "Epidemiology and transmission of hepatitis A virus and hepatitis E virus infections in the United States." Cold Spring Harbor perspectives in medicine 9.4 (2019): a033431.

Bower, William A., Omana V. Nainan, Xiaohua Han, and Harold S. Margolis. "Duration of viremia in hepatitis A virus infection." The Journal of infectious diseases 182, no. 1 (2000); 12-17

Steffen, Robert, Mark A. Kane, Craig N. Shapiro, Nils Billo, K. Janine Stellhorn, and Pierre van Damme. "Epidemiology and prevention of hepatitis A in travelers." Jama 272, no. 11 (1994); 885-889.

Staes, C.J, Schlenker, T.L, Risk, I., Cannon, K.G, Harris, H., Pavia, A.T, Shapiro, C.N, Bell, B.P. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics. (2000); 106(4): e54-e54.

Locarnini SA, Coulepis AG, Stratton AM, Kaldor JA, Gust ID. Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A-specific immunoglobulin M. Journal of Clinical Microbiology, (1979); Apr;9(4):459-65.

Pintó RM, Pérez-Rodríguez FJ, D’Andrea L, de Castellarnau M, Guix S, Bosch A. Hepatitis A virus codon usage: implications for translation kinetics and capsid folding. Cold Spring Harbor perspectives in medicine, (2018); Oct 1;8(10): a031781.

Coulepis, A. G., S. A. Locarnini, N. I. Lehmann, and I. D. Gust. "Detection of hepatitis A virus in the feces of patients with naturally acquired infections. Journal of Infectious Diseases 141, 2 (1980); 151-156.

Møller, A. M., and L. R. Mathiesen. "Detection of immunoglobulin M antibodies to hepatitis A virus by enzyme-linked immunosorbent assay." Journal of clinical microbiology 10, no. 5 (1979); 628-632.

Mao S, Ou X, Zhu D, Chen S, Ma G, Wang M, Jia R, Liu M, Sun K, Yang Q, Wu Y. Development and evaluation of indirect ELISAs for the detection of IgG, IgM and IgA1 against duck hepatitis A virus 1. Journal of virological methods, (2016); Nov 1;237:79-85.

Shah U, Habib Z. Liver failure attributable to hepatitis A virus infection in a developing country. Pediatrics, (2000); Feb 1;105(2):436-8.

Thébault A, Le Saux JC, Pommepuy M, Guyader SL, Lailler R, Denis JB. Quantitative approach of risk management strategies for hepatitis A virus–contaminated oyster production areas. Journal of food protection, (2012); Jul;75(7):1249-57.

Hofmeister MG, Foster MA, Teshale EH. Epidemiology and transmission of hepatitis A virus and hepatitis E virus infections in the United States. Cold Spring Harbor perspectives in medicine, (2019); Apr 1;9(4): a033431.

Sattar SA, Tetro J, Bidawid S, Farber J. Foodborne pread of hepatitis A: Recent studies on virus survival, transfer and inactivation. Canadian Journal of Infectious Diseases, (2000); May 1;11(3):159-63.

Mele A, Stroffolini T, Palumbo F, Gallo G, Ragni P, Balocchini E, Tosti ME, Corona R, Marzolini A, Moiraghi A, SEIEVA Collaborating Group. Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. Journal of hepatology, (1997); Apr 1;26(4):743-7.

Cotter SM, Sansom S, Long T, Koch E, Kellerman S, Smith F, Averhoff F, Bell BP. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. The Journal of infectious diseases, (2003); Apr 15;187(8):1235-40.

Brundage SC, Fitzpatrick NA. Hepatitis A. American family physician, (2006); Jun 15;73(12):2162-8.

Sa-nguanmoo P, Posuwan N, Vichaiwattana P, Vuthitanachot V, Saelao S, Foonoi M, Fakthongyoo A, Makaroon J, Srisingh K, Asawarachun D, Owatanapanich S. Declining trend of hepatitis A seroepidemiology in association with improved public health and economic status of Thailand. PLoS One, (2016); Mar 23;11(3): e0151304.




DOI: http://dx.doi.org/10.62940/als.v9i1.1145

Refbacks

  • There are currently no refbacks.